72 related articles for article (PubMed ID: 17329481)
21. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
[TBL] [Abstract][Full Text] [Related]
22. [Hyperlipidemia - side-effect of "Atypical" neuroleptics?].
Wetterling T
Fortschr Neurol Psychiatr; 2003 Oct; 71(10):535-40. PubMed ID: 14551854
[TBL] [Abstract][Full Text] [Related]
23. Novel antipsychotics and severe hyperlipidemia: comments on the Meyer paper.
Baptista T; Ng Ying Kin NM; Beaulieu S
J Clin Psychopharmacol; 2002 Oct; 22(5):536-7; author reply 538. PubMed ID: 12352285
[No Abstract] [Full Text] [Related]
24. A clinical study of the association of antipsychotics with hyperlipidemia.
de Leon J; Susce MT; Johnson M; Hardin M; Pointer L; Ruaño G; Windemuth A; Diaz FJ
Schizophr Res; 2007 May; 92(1-3):95-102. PubMed ID: 17346932
[TBL] [Abstract][Full Text] [Related]
25. Atypical antipsychotic therapy and hyperlipidemia: a review.
Koro CE; Meyer JM
Essent Psychopharmacol; 2005; 6(3):148-57. PubMed ID: 15869022
[TBL] [Abstract][Full Text] [Related]
26. [Expectations and developments in atypical antipsychotics].
Praxis (Bern 1994); 2004 Aug; 93(35):1392. PubMed ID: 15468579
[No Abstract] [Full Text] [Related]
27. Clinical effectiveness of atypical antipsychotics in dementia.
Tariot PN
J Clin Psychiatry; 2004; 65 Suppl 11():3-4. PubMed ID: 15264964
[No Abstract] [Full Text] [Related]
28. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.
Kinon BJ; Liu-Seifert H; Adams DH; Citrome L
J Clin Psychopharmacol; 2006 Dec; 26(6):632-7. PubMed ID: 17110821
[TBL] [Abstract][Full Text] [Related]
29. The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
Keck PE
J Clin Psychiatry; 2005; 66 Suppl 3():5-11. PubMed ID: 15762829
[TBL] [Abstract][Full Text] [Related]
30. Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis.
Block JJ
Am J Psychiatry; 2006 Oct; 163(10):1838; author reply 1838. PubMed ID: 17012701
[No Abstract] [Full Text] [Related]
31. Observational studies of drugs and mortality.
Ray WA
N Engl J Med; 2005 Dec; 353(22):2319-21. PubMed ID: 16319379
[No Abstract] [Full Text] [Related]
32. Longitudinal effect of olanzapine on fasting serum lipids: a randomized, prospective, 4-month study.
Kinon BJ; Liu-Seifert H; Ahl J; Ahmed S; Baker RW
Ann N Y Acad Sci; 2004 Dec; 1032():295-6. PubMed ID: 15677433
[TBL] [Abstract][Full Text] [Related]
33. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
34. Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: a six-week prospective study in Indian female patients.
Saddichha S; Ameen S; Akhtar S
Schizophr Res; 2007 Sep; 95(1-3):247. PubMed ID: 17644311
[No Abstract] [Full Text] [Related]
35. A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders.
Hellewell JS
J Psychopharmacol; 2006 Mar; 20(2 Suppl):39-45. PubMed ID: 16551671
[TBL] [Abstract][Full Text] [Related]
36. The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
Pae CU; Lim HK; Peindl K; Ajwani N; Serretti A; Patkar AA; Lee C
Int Clin Psychopharmacol; 2008 Jan; 23(1):1-8. PubMed ID: 18090502
[TBL] [Abstract][Full Text] [Related]
37. Olanzapine-induced leucopenia and neutropenia.
Stergiou V; Bozikas VP; Garyfallos G; Nikolaidis N; Lavrentiadis G; Fokas K
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):992-4. PubMed ID: 15950350
[TBL] [Abstract][Full Text] [Related]
38. [Atypical antipsychotics in elderly patients with dementia].
Selbaek G; Engedal K
Tidsskr Nor Laegeforen; 2008 May; 128(9):1060-1. PubMed ID: 18451888
[TBL] [Abstract][Full Text] [Related]
39. Benzodiazepines and antipsychotics: cognitive side effects.
Perna R
J Head Trauma Rehabil; 2004; 19(6):516-8. PubMed ID: 15602314
[No Abstract] [Full Text] [Related]
40. Observational evidence.
Hennekens CH; Buring JE
Ann N Y Acad Sci; 1993 Dec; 703():18-24; discussion 24. PubMed ID: 8192295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
